Original ArticleA Phase II/III, Multicenter, Safety, Efficacy, and Pharmacokinetic Study of Dexmedetomidine in Preterm and Term Neonates☆,
Cited by (0)
- ☆
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Sponsored and funded by Hospira, Inc (Lake Forest, IL). G.dR. and W.W. are employees of Hospira, the manufacturer of Precedex (dexmedetomidine HCl), and hold Hospira stock options. The sponsor was involved in study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the manuscript for publication. Assistance in the preparation of this manuscript was provided by MMS Holdings Inc (editing for grammatical errors, preparation of Tables and Figures, and proper formatting for references). The other authors declare no conflicts of interest.
Registered with ClinicalTrials.gov: NCT01159262 and NCT01508455.